Name: UMIN ID:
Unique ID issued by UMIN | UMIN000014635 |
---|---|
Receipt number | R000017025 |
Scientific Title | Evaluation of L/N type Ca2+ channel blocker (cilnidipine) in hypertension complicated diabetes or sleep apnea syndrome ; Trial for the effects of improvementof arteriosclerosis and renal function. |
Date of disclosure of the study information | 2014/07/24 |
Last modified on | 2014/11/20 10:23:21 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/07/24 14:56:21 | ||
2 | Update | 2014/07/24 15:02:57 | Anticipated trial start date |
|
3 | Update | 2014/08/08 16:48:47 | ||
4 | Update | 2014/08/14 11:54:23 | ||
5 | Update | 2014/09/06 10:33:23 | ||
6 | Update | 2014/11/18 10:38:18 | Key exclusion criteria Key exclusion criteria |
|
7 | Update | 2014/11/18 10:40:07 | Public title |
|
8 | Update | 2014/11/20 10:23:21 | Primary outcomes Primary outcomes Key secondary outcomes |